 Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , Aug. 8, 2022 PRNewswire -- Protalix BioTherapeutics, Inc. NYSE American: PLX TASE: PLX, a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today announced that it will release its financial results for the second quarter 2022 and provide a business update on Monday, August 15, 2022. 